Department of Immunology and Infectious Diseases, Harvard School of Public Health , Boston, MA , USA.
Crit Rev Biochem Mol Biol. 2014 Mar-Apr;49(2):91-101. doi: 10.3109/10409238.2013.869543. Epub 2013 Dec 13.
One of the challenges in clinical infectious diseases is the problem of chronic infections, which can require long durations of antibiotic treatment and often recur. An emerging explanation for the refractoriness of some infections to treatment is the existence of subpopulations of drug tolerant cells. While typically discussed as "persister" cells, it is becoming increasingly clear that there is significant heterogeneity in drug responses within a bacterial population and that multiple mechanisms underlie the emergence of drug tolerant and drug-resistant subpopulations. Many of these parallel mechanisms have been shown to affect drug susceptibility at the level of a whole population. Here we review mechanisms of phenotypic drug tolerance and resistance in bacteria with the goal of providing a framework for understanding the similarities and differences in these cells.
临床传染病学面临的挑战之一是慢性感染问题,此类感染通常需要长时间使用抗生素治疗,而且经常反复发作。有些感染对治疗产生抗药性的一个新解释是,存在对药物具有耐受性的细胞亚群。虽然通常将这些细胞称为“持续存在细胞”,但越来越明显的是,在细菌群体中,药物反应存在明显的异质性,并且有多种机制导致药物耐受性和耐药性亚群的出现。许多这些平行机制已被证明会影响整个群体的药物敏感性。在这里,我们回顾了细菌中表型药物耐受性和耐药性的机制,旨在为理解这些细胞的相似性和差异提供一个框架。